This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Sandra DePorter, PhD
Senior Director, Discovery Biology at Adaxion Therapeutics
Speaker

Profile

Sandra DePorter is the Senior Director of Discovery Biology at ADAXION Therapeutics and a founding member of the team that developed its core technology, which originated at Inception Therapeutics. At Inception, she was Associate Director of Protein Engineering and supported seed-stage ventures like Lycia, Belharra, and Light Horse Therapeutics. Previously, she was an Investigator at Novartis (GNF), focusing on antibody conjugates for immuno-oncology. Prior to Novartis, Sandra completed a joint postdoctoral fellowship in bioengineering and cardiovascular medicine at Stanford. Sandra holds a Ph.D. in chemistry from Colorado State University and B.S. in chemistry from the University of Wisconsin-Madison.

Agenda Sessions

  • ADAx—A Novel Platform for Overcoming Immunogenicity in Biologics

    9:15am